Literature DB >> 32079027

Serum Irisin Concentrations in Severely Inflamed Patients.

Silvio Buscemi1,2, Davide Corleo1,2, Sonya Vasto3, Carola Buscemi1,2, Anna Maria Barile1,2, Giuseppe Rosafio1,2, Cristiana Randazzo1,2, Walter Currenti4, Fabio Galvano4.   

Abstract

Irisin is a recently discovered exercise-induced myokine that has been attributed the role of favoring white-to-brown adipose tissue trans-differentiation. We confirmed in a population-based cohort that irisin serum concentrations are independently correlated with the habitual level of physical activity, but we also observed an independent correlation with serum concentrations of high-sensitivity C-reactive protein (hs-CRP), thus suggesting that inflammation may influence irisin production. In order to investigate the association between irisin and inflammation, we measured serum irisin concentrations in a group of inflamed inpatients. We hypothesized that if an association between irisin and inflammation exists, severely inflamed patients, even though physically inactive, might also exhibit high serum irisin levels. We recruited 40 consecutive markedly inflamed inpatients on the basis of serum CRP levels. Their irisin serum concentrations (Phoenix Europe, Germany) were compared with those obtained in the population-based cohort of the ABCD_2 study (Alimentazione, Benessere Cardiovascolare e Diabete) (ISRCTN15840340). The inflamed patients exhibited higher serum irisin concentrations (median: 6.77 ng/ml; 95% CI for the median: 5.97-7.23) than those observed in the ABCD cohort (median: 5.21 ng/ml; 95% CI for the median: 5.08-5.30; p <0.001). Irisin concentrations were significantly correlated with age (r=-0.44; p <0.001), creatinine (r=-0.35; p <0.05), and fibrinogen (r=0.40; p <0.05) concentrations. No association was observed between irisin, interleukine-6 and tumor necrosis factor alpha. This study confirms the association between inflammation and irisin concentrations. Further studies are needed to understand the mechanisms underlying this association and its possible clinical implications. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 32079027     DOI: 10.1055/a-1111-9249

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  2 in total

Review 1.  The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity.

Authors:  Hui Li; Fang Wang; Mu Yang; Jiao Sun; Yi Zhao; Dongqi Tang
Journal:  Int J Endocrinol       Date:  2021-03-18       Impact factor: 2.803

2.  Irisin supports integrin-mediated cell adhesion of lymphocytes.

Authors:  Phyoe Kyawe Myint; Atsushi Ito; Michael G Appiah; Gideon Obeng; Samuel Darkwah; Eiji Kawamoto; Arong Gaowa; Eun Jeong Park; Motomu Shimaoka
Journal:  Biochem Biophys Rep       Date:  2021-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.